ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ABUS announcements Arbutus Biopharma Corporation announcements and dividends declared NASDAQ

Arbutus Biopharma Corporation Complete list of announcements declared & dividend announcements by Arbutus Biopharma Corporation ABUS

Arbutus Biopharma Corporation ABUS listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Arbutus Biopharma Corporation ABUS

Arbutus Biopharma Reacquires Rights to Imdusiran in Greater China, Concludes Partnership with Qilu Pharmaceutical
Arbutus reclaims rights to imdusiran in Greater China and establishes a new Scientific Advisory Board for chronic HBV treatment.
Announcement as on 25 June 2025

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates
Arbutus Biopharma (ABUS) came out with a quarterly loss of [CO].10 per share in line with the Zacks Consensus Estimate. This compares to loss of [CO].12 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 06 November 2024

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates
Arbutus Biopharma (ABUS) came out with a quarterly loss of [CO].10 per share in line with the Zacks Consensus Estimate. This compares to loss of [CO].12 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 06 November 2024

Arbutus Biopharma Reports Claim Construction Ruling In Patent Infringement Lawsuit Against Moderna
(RTTNews) - Arbutus Biopharma (ABUS) issued statement regarding the claim construction ruling of the U.S. District Court for the District of Delaware in the lawsuit brought by Arbutus and its licensee Genevant Sciences against Moderna seeking damages for i
Announcement as on 04 April 2024

Announcements by Arbutus Biopharma Corporation first page |

ABUS Arbutus Biopharma Corporation current price & indicator signals

Moving Averages for Arbutus Biopharma Corporation

  • 5Day Average: 4.73
  • 12Day Average: 4.74
  • 20Day Average: 4.7
  • 50Day Average: 4.57
  • 100Day Average: 4.4
  • 150Day Average: 4.04
  • 200Day Average: 3.85

ABUS Indicators & signals

Indicator MACD (12,26,9)

4.71, 4.66, 0.06
Indicator MACD is in positive zone

Indicator ADX (14)

0, 29.17, 29.17
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ABUS Arbutus Biopharma Corporation are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Fri Jan 2026 4.62 4.59 to 4.73 -0.65% 0.74 times
08 Thu Jan 2026 4.65 4.59 to 4.87 -4.71% 1.13 times
07 Wed Jan 2026 4.88 4.79 to 5.00 1.88% 1.29 times
06 Tue Jan 2026 4.79 4.65 to 4.83 1.7% 0.72 times
05 Mon Jan 2026 4.71 4.66 to 4.84 -1.26% 0.66 times
02 Fri Jan 2026 4.77 4.65 to 4.98 -0.83% 1.33 times
31 Wed Dec 2025 4.81 4.59 to 5.05 4.11% 2.53 times
30 Tue Dec 2025 4.62 4.55 to 4.75 -2.12% 0.77 times
29 Mon Dec 2025 4.72 4.66 to 4.81 -1.26% 0.45 times
26 Fri Dec 2025 4.78 4.66 to 4.82 -0.21% 0.49 times
24 Wed Dec 2025 4.79 4.70 to 4.91 2.35% 0.63 times
23 Tue Dec 2025 4.68 4.64 to 4.80 -0.85% 0.69 times

Videos related to: ABUS announcements Arbutus Biopharma Corporation announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ABUS announcements Arbutus Biopharma Corporation announcements and dividends declared NASDAQ

 

Back to top